top of page
IMG_0251 (1)_edited_edited.jpg

Keep up with our latest developments

News & Events

15th November, 2024

MUNICH, GERMANY, November 15, 2024 / LARALAB GmbH, a leader in AI-powered medical imaging for interventional cardiology, announces the launch of its CE marked Aortic Valve Module. This module offers automatic, high-precision segmentations and measurements, crucial for advancing Transcatheter Aortic Valve Replacement in patients with Aortic Stenosis or Regurgitation  | Read press release

30th October, 2024

MUNICH, GERMANY, October 30, 2024 / LARALAB GmbH, a pioneer in AI-driven medical imaging for cardiology and heart surgery, announces the launch of its new Mitral Valve Module. This addition to LARALAB’s suite is CE marked and marks a significant advancement in screening and decision-making for transcatheter mitral valve repair and replacement (TMVR). | Read press release

13th May, 2024

MUNICH, GERMANY, May 13, 2024 /EINPresswire.com/ LARALAB Launches Groundbreaking New Product 'REC - Rapid Eligibility Check'. REC offers rapid, AI-driven assessments of patient eligibility for various heart procedures, significantly improving the screening and decision-making process for structural heart teams worldwide. | Read press release

2nd May, 2024

MUNICH, GERMANY, May 2, 2024 /EINPresswire.com/ LARALAB GmbH, a leader in AI-driven medical imaging for interventional cardiology, today announced the release of the 'LARALAB Gen2 Platform' | Read press release

20th October 2023

LARALAB announces the closing of a 5.7 M € Series A2 financing round to further drive platform innovations together with heart centers and device companies. LARALAB’s CE marked imaging and data analytics platform for structural heart interventions supports clinical decision making and enables data insights with the power of LARALAB's proprietary Deep Learning and cloud technology. The financing round was led by a family office investor from Hamburg, Germany, experienced in the structural heart market.

bottom of page